# Spironolactone and Hydrochlorothiazide

NDC: 42292-017
Generic name: spironolactone and hydrochlorothiazide
Labeler / Manufacturer: Mylan Institutional Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20170512

FDA application: ANDA086513

## Active ingredients

- HYDROCHLOROTHIAZIDE: 25 mg/1
- SPIRONOLACTONE: 25 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"42292-017"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=42292-017
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f2a4fbc0-650b-440d-9555-c1720fe0fe35